Two in three California voters agree American democracy is under attack. Trump and his allies are only increasing their threats, looking for new ways to silence voters’ voices b ...

Those who take the time to understand a problem before solving it are faster in the end. An account of an counterintuitive development process.

The Berlin Senate is expanding video surveillance and relying on automated behavioral analysis in front of the House of Representatives and at crime hotspots.

As major film festivals struggle with tackling complex political issues at a time of great global unrest, CPH:DOX is pushing forward with prodding at the root of sensitive conversations surrounding ...

New research from Prenzler Group says Island Pharmaceuticals offers a compelling investment opportunity ... Read More The post New research on Island Pharmaceuticals highlights a “Compelling ...

Highlights: Uranium and High-Grade REE Mineralization at Surface: Significant REE mineralization grades associated with varying uranium concentrations of uranium hosted in outcrop and boulder grab sam ...

An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...

NEW DELHI, March 11, 2026 /PRNewswire/ -- According to the latest market research study published by MarkNtel Advisors, the Global Hypersonic Weapons, Missiles, and Glide Vehicles Market is projected ...

RTX reached a full-power test milestone on its hybrid-electric propulsion demonstrator, achieving 1MW motor rated power, according to a June 19, 2023 company release. The test validated the company’s ...

A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...

Deepdub, a foundational voice AI company pioneering expressive voice technologies, announced today the launch of its latest AI speech ...

Insmed Incorporated ( INSM) Leerink Global Healthcare Conference 2026 March 10, 2026 8:00 AM EDT Good morning. Welcome to this fireside chat with Insmed. I'm Joe Schwartz from the biopharma equity ...